This laboratory study reports that brilliant blue FCF is an alternative, nontoxic marking dye that may improve human saphenous vein conduit function and decrease intimal hyperplasia.
Li and coauthors investigate whether pressure distension during vein graft preparation leads to endothelial injury and intimal thickening.
To evaluate the early experience with transfemoral transcatheter aortic valve replacement (TAVR), Omer et al reviewed the records of all patients who underwent the procedure during the first year of their program. All patients received TAVR with the SAPIEN transcutaneous valve, and outcomes were assessed. See the Invited Commentary by Kelly and Mudy.
Harskamp et al evaluate the effect of vein graft preservation solutions on vein graft failure and clinical outcomes in patients undergoing coronary artery bypass graft (CABG) surgery. See the Invited Commentary by Yuh.
Bakaeen et al review a recently launched pilot program aimed at enhancing patient enrollment and improving surgical trial operations at individual sites and nationally. See also the invited commentary by Machiedo.